Evidence map›Paper›PMID 32493346›Full record

ArticleFluids and barriers of the CNS2020

Advances in blood-brain barrier modeling in microphysiological systems highlight critical differences in opioid transport due to cortisol exposure.

Jacquelyn A Brown, Shannon L Faley, Yajuan Shi, Kathleen M Hillgren, Geri A Sawada, Thomas K Baker, John P Wikswo, Ethan S Lippmann

Open access · goldAbstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Comparative analysis of the uptake of the HFluids and barriers of the CNS · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Current neuropharmacology · 2024
    Review
  14. Article
  15. Article
  16. Towards Novel BiomimeticBioengineering (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jacquelyn A BrownVanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, TN, USA.
Shannon L FaleyVanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, TN, USA.
Yajuan ShiDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Kathleen M HillgrenDepartments of ADME and Toxicology, Eli Lilly and Company, Indianapolis, IN, USA.
Geri A SawadaDepartments of ADME and Toxicology, Eli Lilly and Company, Indianapolis, IN, USA.
Thomas K BakerDepartments of ADME and Toxicology, Eli Lilly and Company, Indianapolis, IN, USA.
John P WikswoVanderbilt Institute for Integrated Biosystems Research and Education, Vanderbilt University, Nashville, TN, USA. john.p.wikswo@vanderbilt.edu.
Ethan S LippmannDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA. ethan.s.lippmann@vanderbilt.edu.ORCID http://orcid.org/0000-0001-5703-5747
Vanderbilt University · USEli Lilly (United States) · US

Funding

Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological modelsUH3TR002097 · NCATS · VANDERBILT UNIVERSITY · PI ESS, KEVIN C, NEELY, MAJA DIANA · 2019 to 2021
$4.6M
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological modelsUG3TR002097 · NCATS · VANDERBILT UNIVERSITY · PI ESS, KEVIN C, NEELY, MAJA DIANA · 2017 to 2018
$2.5M
NCATS NIH HHS UG3 TR002097NCATS NIH HHS UH3 TR002097NICHD NIH HHS U54 HD083211NIH HHS 5UG3TR002097-02NIH HHS 5UG3TR002097-02S1
6 · The paper itself

Abstract

backgroundThe United States faces a national crisis involving opioid medications, where currently more than 130 people die every day. To combat this epidemic, a better understanding is needed of how opioids penetrate into the central nervous system (CNS) to facilitate pain relief and, potentially, result in addiction and/or misuse. Animal models, however, are a poor predictor of blood-brain barrier (BBB) transport and CNS drug penetration in humans, and many traditional 2D cell culture models of the BBB and neurovascular unit have inadequate barrier function and weak or inappropriate efflux transporter expression. Here, we sought to better understand opioid transport mechanisms using a simplified microfluidic neurovascular unit (NVU) model consisting of human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes.

methodsHuman primary and induced pluripotent stem cell (iPSC)-derived BMECs were incorporated into a microfluidic NVU model with several technical improvements over our previous design. Passive barrier function was assessed by permeability of fluorescent dextrans with varying sizes, and P-glycoprotein function was assessed by rhodamine permeability in the presence or absence of inhibitors; quantification was performed with a fluorescent plate reader. Loperamide, morphine, and oxycodone permeability was assessed in the presence or absence of P-glycoprotein inhibitors and cortisol; quantification was performed with mass spectrometry.

resultsWe first report technical and methodological optimizations to our previously described microfluidic model using primary human BMECs, which results in accelerated barrier formation, decreased variability, and reduced passive permeability relative to Transwell models. We then demonstrate proper transport and efflux of loperamide, morphine, and oxycodone in the microfluidic NVU containing BMECs derived from human iPSCs. We further demonstrate that cortisol can alter permeability of loperamide and morphine in a divergent manner.

conclusionsWe reveal a novel role for the stress hormone cortisol in modulating the transport of opioids across the BBB, which could contribute to their abuse or overdose. Our updated BBB model represents a powerful tool available to researchers, clinicians, and drug manufacturers for understanding the mechanisms by which opioids access the CNS.

Indexed as

Models, NeurologicalAnalgesics, OpioidAstrocytesBlood-Brain BarrierCells, CulturedCoculture TechniquesEndothelial CellsHumansHydrocortisoneInduced Pluripotent Stem CellsMicrovesselsAnalgesics, OpioidHydrocortisone

Identifiers

PMID32493346
PMCPMC7269003
OpenAlexW3032541059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.